Resources - Search Results | Barrington James

Back to resources

Displaying 9 - 16 of 68

The Next Frontier in Asia-Pacific Regulatory Affairs: AI as Co-Regulator
For decades, regulatory affairs has been defined by process discipline and meticulous compli...

By Wanyun Nie September 5th, 2025
Medical Device
Why Commercial Hiring Models in Cardiology Need a Critical Rethink
Robotic-assisted platforms, AI-powered diagnostics, and minimally invasive valve technologie...

By Suzannah Bangle September 4th, 2025
AI’s Next Frontier: Protein Models, OpenAI Collaborations, and the Future of Life Sciences
With massive credence AI has transcended its bounds from adaptation to evolution. The years&...

By Barrington James September 2nd, 2025
Company News
Trump's 15% EU Pharma Tariff & Price Match Ultimatum: What This Means
On the 28th of July, the US and the EU agreed a baseline of 15% import tariff that explicitl...

By Barrington James August 5th, 2025
Strategic Solutions Group
Building out Site Research Capabilities: A Barrington James Perspective
The clinical research industry is experiencing a pivotal shift. Increasingly complex protoco...

By Bryan Katz July 21st, 2025
Strategic Solutions Group
Why Sponsors Are Rethinking the CRO Status Quo?
CRO Slowdown and Rising Pressures.Clinical development leaders are facing a perfect storm of...

By Barrington James July 15th, 2025
Company News
Merck to Acquire Verona Pharma for $10 Billion, Adding Breakthrough COPD Drug Ohtuvayre
The deal in detailIn this agreement, Merck will pay $107 each American Depository Share, val...

By Barrington James July 9th, 2025
Strategic Solutions Group
Taking Control: Driving Efficiency and Innovation with Embedded, In-House Clinical Trial Teams
Never has a pharma or biotech’s use of capital been under more scrutiny. Consequently, regar...

By Bryan Katz July 1st, 2025